152 related articles for article (PubMed ID: 11098494)
1. UFT/leucovorin plus vinorelbine combination for advanced breast cancer.
Fumoleau P; Déporte R; Kerbrat P; Bonneterre J; Fargeot P
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):50-5. PubMed ID: 11098494
[TBL] [Abstract][Full Text] [Related]
2. UFT plus oral calcium folinate/vinorelbine for advanced breast cancer.
Fumoleau P; Déporte-Fety R; Kerbrat P; Laguerre B
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):86-90. PubMed ID: 10442371
[TBL] [Abstract][Full Text] [Related]
3. Modelling of ftorafur and 5-fluorouracil pharmacokinetics following oral UFT administration. A population study in 30 patients with advanced breast cancer.
Urien S; Fumoleau P; Campone M; Kerbrat P; Bonneterre J; Fargeot P; Deporte-Fety R
Cancer Chemother Pharmacol; 2003 Aug; 52(2):99-107. PubMed ID: 12768319
[TBL] [Abstract][Full Text] [Related]
4. A phase I study of UFT-oral vinorelbine in metastatic breast cancer.
Ferrero JM; Largillier R; Michel C; Amiot V; Milano G; Hébert C; Mari V; Courdi A; Figl A; Follana P; Barrière J; Chamorey E
Oncology; 2011; 81(2):73-8. PubMed ID: 21968516
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL
J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535
[TBL] [Abstract][Full Text] [Related]
6. UFT/leucovorin plus irinotecan in advanced or metastatic colorectal cancer.
Price T; Hill M
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):28-31. PubMed ID: 11098487
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day schedule.
Pazdur R; Lassere Y; Diaz-Canton E; Ho DH
Cancer Invest; 1998; 16(3):145-51. PubMed ID: 9541627
[TBL] [Abstract][Full Text] [Related]
8. A phase 2 study of a fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in a 3-times-daily regimen to treat patients with recurrent metastatic breast cancer.
Hortobagyi GN; Heim W; Hutchins L; Rivera E; Mason B; Booser DJ; Kirshner J
Cancer; 2010 Mar; 116(6):1440-5. PubMed ID: 20091835
[TBL] [Abstract][Full Text] [Related]
9. A phase I study. UFT/leucovorin combined with paclitaxel for anthracycline-pretreated advanced breast cancer.
Scholz U; Lück HJ; Canzler U; Robner D; Kühnle H
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):44-6. PubMed ID: 11098492
[TBL] [Abstract][Full Text] [Related]
10. Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancer.
Goss PE; Fine S; Gelmon K; Rudinskas L; Ottaway J; Myles J; James K; Paul K; Rodgers A; Pritchard KI
Cancer Chemother Pharmacol; 1997; 41(1):53-60. PubMed ID: 9443614
[TBL] [Abstract][Full Text] [Related]
11. Effect of food on the oral bioavailability of UFT and leucovorin in cancer patients.
Damle B; Ravandi F; Kaul S; Sonnichsen D; Ferreira I; Brooks D; Stewart D; Alberts D; Pazdur R
Clin Cancer Res; 2001 Mar; 7(3):517-23. PubMed ID: 11297242
[TBL] [Abstract][Full Text] [Related]
12. Phase I and pharmacokinetic evaluations of UFT plus oral leucovorin.
Pazdur R
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):35-9. PubMed ID: 9348565
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
[TBL] [Abstract][Full Text] [Related]
14. A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancer.
Hortobagyi GN; Young RR; Karwal M; Ibrahim NK; Hermann R; Murray JL; Watkins SP; Gore I
Cancer; 2010 May; 116(10):2301-6. PubMed ID: 20225231
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer.
Meropol NJ; Sonnichsen DS; Birkhofer MJ; Ferreira I; Noel D
Cancer Chemother Pharmacol; 1999; 43(3):221-6. PubMed ID: 9923552
[TBL] [Abstract][Full Text] [Related]
16. UFT plus oral folinic acid with alternating oral and intravenous vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.
Coşkun U; Kaya AO; Alkis N; Buyukberber S; Alici S; Celenkoglu G; Uncu D; Ozkan M; Sevinc A; Benekli M
Onkologie; 2009 Oct; 32(10):562-6. PubMed ID: 19816072
[TBL] [Abstract][Full Text] [Related]
17. Irinotecan and UFT/leucovorin in patients with advanced cancers.
Stevenson JP; Redlinger M; Sun W; Haller D; O'Dwyer PJ
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):91-2. PubMed ID: 11098504
[TBL] [Abstract][Full Text] [Related]
18. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Hoff PM; Pazdur R; Benner SE; Canetta R
Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel and UFT plus oral calcium folinate in pretreated metastatic breast cancer.
Klaassen U; Borquez D; Lang S; Oberhoff C; Harstrick A; Seeber S; Benner S
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):71-3. PubMed ID: 10442367
[TBL] [Abstract][Full Text] [Related]
20. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
